Tunable 18F-Labeling of Erlotinib-Based Small Molecule Nanodrugs for Rapid PET Imaging and Targeted Therapy.
Small molecule nanodrugs (SMNs) offer unique advantages for cancer therapy, yet accurately tracking their in vivo fate without perturbing their native assembly remains challenging. Here, we report a spacer engineering strategy that enables efficient 1 8F-labeling while preserving SMNs self-assembly. Erlotinib-based amp...